Articles From: Hardinge Inc. Reports Second Quarter Results to Teva Receives European Marketing Authorization for Lonquex® (XM22 lipegfilgrastim)


2013/8/8
Second quarter diluted earnings per share were $0.19 compared with $0.31 in the prior-year period; Non-GAAP diluted earnings per share were $0.34 after adjusting for acquisition related expenses Operating margin improved by 2.9 points to 3.6% of sales over the trailing first quarter; Non-GAAP operating margin was 5.8% after adjusting for acquisition related expenses Cash generated by operations improved to $8.7 million in the second quarter from $3.8 million in the prior-year's second quarter ELMIRA, N.Y., Aug.
Sign-up for Hardinge Inc. Reports Second Quarter Results investment picks
2013/8/8
WORCESTER, Mass., Aug.
Sign-up for World Energy Solutions Announces Q2 Financial Results investment picks
Opexa Therapeutics, Inc. (NASDAQ:OPXA) , a biotechnology company developing Tcelna®, a patient-specific T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced the pricing of an underwritten public offering of 12 million shares of its common stock at a price to the public of $1.50 per share.
Sign-up for Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock investment picks
Bellatrix Exploration Ltd.
Sign-up for Bellatrix Exploration Ltd. Announces Second Quarter 2013 Financial Results investment picks
2013/8/8
SAP® ERP Foundation Extension Helps Fast-Growing Companies Run Like Never Before SAO PAULO , Aug.
Sign-up for SAP Supports Customer Growth in Emerging Markets by Combining SAP® ERP With Mobile, Analytic and Cloud Innovations investment picks
2013/8/8
Investments Strengthen Nation's Fastest and Most Reliable 4G LTE Network, Largest 4G Network Project Velocity IP Investments Result in New Cell Sites, Small Cells and Distributed Antenna Systems to Enhance Network Performance Across New Hampshire CONCORD, N.H. , Aug.
Sign-up for AT&T Invests $25 Million In New Hampshire Wireless And Wireline Networks In First Half Of 2013 investment picks
2013/8/8
http://media.marketwire.com/attachments/201109/20732_RKN.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1040977&ProfileId=051205&sourceType=1 TORONTO --
Sign-up for Tier 1 APAC Operator Deploys Redknee's Policy Management Solution for VoLTE investment picks
2013/8/8
-- 2Q13 Contract Sales Exceeds Previous Guidance by 30.7% -- --
Sign-up for Xinyuan Real Estate Co., Ltd. Announces Second Quarter 2013 Financial Results investment picks
2013/8/8
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0890933001&sourceType=1 http://media3.marketwire.com/docs/torexlogofixedLG.png TORONTO, ONTARIO --
Sign-up for Torex Reports Second Quarter Results investment picks
Investments Strengthen Nation's Fastest and Most Reliable 4G LTE Network, Largest 4G Network Project Velocity IP Investments Result in New Cell Sites, Small Cells and Distributed Antenna Systems to Enhance Network Performance Across New Mexico ALBUQUERQUE, N.M. , Aug.
Sign-up for AT&T Invests $35 Million In New Mexico Wireless And Wireline Networks In First Half Of 2013 investment picks
- U.S. Revenues of $25.1 million, up from $4.2 million in Second Quarter of 2012; Reflects Strong Initial Commercialization of HVAD® Pump in U.S. - - Conference call today at 8:00 a.m. U.S. E.T. - FRAMINGHAM, Mass.
Sign-up for HeartWare International Reports $50.8 Million In Second Quarter 2013 Revenue; 75% Increase From Second Quarter Of 2012 investment picks
AVEO Oncology (NASDAQ: AVEO) today reported second quarter 2013 financial results.
Sign-up for AVEO Reports Second Quarter 2013 Financial Results investment picks
Penn West Exploration Announces Results of Contingent Resources Studies Canada NewsWire (1) All estimates of Resources and Reserves in the table represent the best estimate (or in the case of Reserves, the Proved plus Probable Reserves) of Company Gross interests (Total Company interest before deductions and excluding royalty interests). The best estimate is considered to be the best estimate of the quantity of resources that will actually be recovered.
Sign-up for Penn West Exploration Announces Results of Contingent Resources Studies investment picks
2013/8/7
By V.
Sign-up for UPDATE: Asia stocks climb back from heavy losses investment picks
2013/8/8
ATLANTA , Aug.
Sign-up for Gray Reports Operating Results For the Three-Month and Six-Month Periods Ended June 30, 2013 investment picks
2013/8/8
SHANGHAI, China, Aug.
Sign-up for JA Solar and the VDE Institute Launch Solar Module Bankability Initiative investment picks
2013/8/7
GERMANTOWN, Md.
Sign-up for Intrexon Prices Initial Public Offering investment picks
Cervus Equipment Corp.
Sign-up for Cervus Equipment Corp. announces second quarter 2013 results investment picks
2013/8/8
TSX, NYSE MKT: BXE CALGARY , Aug.
Sign-up for Bellatrix Exploration Ltd. Announces Second Quarter 2013 Financial Results investment picks
London (MarketWatch)-- Costco Wholesale Corp.
Sign-up for Costco July comparable sales up 4% investment picks
2013/8/7
GLENDALE, Calif.
Sign-up for DreamWorks Animation Announces Pricing of 6.875% Senior Notes Due 2020 investment picks
Ascent Solar Technologies, Inc. (NASDAQ: ASTI) , a developer of state-of-the-art, flexible thin-film photovoltaic modules, integrated into the company’s EnerPlex TM series of consumer products, reported results for the second quarter ended June 30, 2013.
Sign-up for Ascent Solar Reports Second Quarter 2013 Results investment picks
2013/8/8
AMSTERDAM , Aug.
Sign-up for AVG Announces September 2013 Extraordinary General Meeting of Shareholders investment picks
2013/8/8
Fitch Ratings has affirmed the credit ratings of Kimco Realty Corporation as shown below (NYSE: KIM) and assigned initial ratings to two wholly-owned unsecured issuing subsidiaries: Kimco North Trust III and KRC Lending S.A. de C.V. SOFOM ENR (collectively, Kimco or the company). Certain obligations of Kimco North Trust III previously listed under Kimco Realty Corporation were affirmed and now listed under their respective issuers.
Sign-up for Fitch Affirms Kimco's IDR at 'BBB+'; Outlook Stable investment picks
Avid ® (NASDAQ: AVID) today announced that it provided its long proven and trusted technology solutions, including Media Composer, the preeminent nonlinear editing solution, to support the Sundance Institute’s annual Directors Lab at the Sundance Resort in Utah.
Sign-up for Avid Partners with Renowned Sundance Institute’s Annual Directors Lab investment picks
2013/8/8
Peter moves from Lew'Lara\TBWA to TBWA\Chiat\Day LA to head up Gatorade work LOS ANGELES , Aug.
Sign-up for TBWA\Chiat\Day LA appoints Peter Ravailhe to Managing Director of Gatorade business investment picks
2013/8/8
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) announced today that the European Commission has granted marketing authorization for Lonquex ® (lipegfilgrastim). This approval provides the regulatory framework for the commercialization of Lonquex ® in all twenty eight countries of the European Union plus Norway, Iceland and Liechtenstein.
Sign-up for Teva Receives European Marketing Authorization for Lonquex® (XM22 lipegfilgrastim) investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Hardinge Inc. Reports Second Quarter Results to Teva Receives European Marketing Authorization for Lonquex® (XM22 lipegfilgrastim)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity